Vaccines

Bavarian Nordic’s chikungunya vaccine candidate was shown to be highly immunogenic in participants across age groups, according to data presented at IDWeek.

BOSTON — An ongoing outbreak of cholera in Haiti has infected nearly 1 million people, and the situation will not improve unless action is taken, Louise Ivers, MD, MPH, FIDSA, FASTMH, told Healio at IDWeek.

BOSTON — In this video, Jodie A. Dionne, MD, MSPH, associate professor of medicine at the University of Alabama at Birmingham, recaps her IDWeek presentation on vaccines and sexually transmitted infections.

The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó, PhD, and Drew Weissman, MD, PhD, for discoveries that were crucial in developing messenger RNA vaccines to combat the spread of COVID-19, according to a press release.

Despite experts warning of the dangers of influenza, COVID-19, respiratory syncytial virus and pneumococcal disease this fall and winter, survey data shows that many U.S. adults underestimate the seriousness of these infections.

The FDA approved updated COVID-19 vaccines last week that target omicron XBB subvariants of SARS-CoV-2, which have become the predominant SARS-CoV-2 viruses worldwide.

The CDC recently recommended updated versions of the Moderna and Pfizer-BioNTech COVID-19 vaccines aimed at omicron XBB subvariants of SARS-CoV-2, following their approval by the FDA.

The CDC on Tuesday recommended the updated monovalent COVID-19 vaccines for people aged older than 6 months.

The FDA on Monday approved and authorized updated COVID-19 vaccines from Moderna and Pfizer-BioNTech that target omicron XBB subvariants of SARS-CoV-2.

PHILADELPHIA — In this video, Paul A. Offit, MD, discusses a panel at the World Anti-Microbial Resistance Congress and Disease Prevention & Control Summit that covered vaccine safety.